Kazuhiro Sato

Kazuhiro Sato

Auto-generated profile, based on publicly available information

Kazuhiro Sato

Nagaoka Red Cross Hospital, Niigata, Japan

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2013 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
SMSatoru Miura
Satoru Miura
SWSatoshi Watanabe
Satoshi Watanabe
KSKazuhiro Sato
Kazuhiro Sato
MMMasato Makino
Masato Makino
OKOsamu Kobayashi
Osamu Kobayashi
HYHirohisa Yoshizawa
Hirohisa Yoshizawa

4 October 2011 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
MKMasahiro Kitada
Masahiro Kitada
SHSatoshi Hayashi
Satoshi Hayashi
YMYoshinari Matsuda
Yoshinari Matsuda
KSKazuhiro Sato
Kazuhiro Sato
NMNaoyuki Miyokawa
Naoyuki Miyokawa
TSTadahiro Sasajima
Tadahiro Sasajima
Intracystic carcinoma of the breast is a type of breast cancer with favorable prognosis where cancer arises from the cystic wall. However, it is a relatively rare disease, and no general consensus has been reached on its definition, including pathogenesis, extramural invasion, and lymph node metastasis.

18 December 2016 in Respiratory Medicine Case Reports
Verified
Journal Article
Open access
PDF file
NONobumasa Ohara
Nobumasa Ohara
MKMasanori Kaneko
Masanori Kaneko
MIMasahiro Ikeda
Masahiro Ikeda
FIFumio Ishizaki
Fumio Ishizaki
KSKazuya Suzuki
Kazuya Suzuki
KKKyuzi Kamoi
Kyuzi Kamoi
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder caused by heterozygous germline mutations in the tumor suppressor gene MEN1, which encodes a nuclear protein, menin. MEN1 is characterized by the combined occurrence of tumors involving the pituitary gland, pancreatic islets, and parathyroid glands. Additionally, patients with MEN1 often exhibit adrenal tumors. Although most MEN1-associated tumors are benign, malignant lesions arising in these endocrine organs have been reported. Additionally, malignant diseases of non-endocrine organs concomitant with MEN1 have also been reported. Here, we report a rare case of a MEN1 patient who exhibited adrenocortical carcinoma (ACC) and lung adenocarcinoma (LAC).

1 May 2025 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
KYKazuhiro Yatera
Kazuhiro Yatera
Zhang WangZhang Wang
Zhang Wang
YSYoko Shibata
Yoko Shibata
NINobuhisa Ishikawa
Nobuhisa Ishikawa
THTetsuya Homma
Tetsuya Homma
PJPaul W Jones
Paul W Jones
Background: In Western studies, lung microbiome changes are reported in patients with chronic obstructive pulmonary disease (COPD) and are associated with poorer outcomes, but similar studies in Asian patients or those with less severe COPD are limited. Methods: The Acute Exacerbation and Respiratory InfectionS in COPD Japan (AERIS-J; jRCT1080224632/NCT03957577) was a prospective, non-interventional study to evaluate sputum microbiome diversity at baseline and after 12 months (V2; exploratory analysis), in patients aged 40– 80 years with stable COPD (June 2019–June 2022). Baseline sputum potentially pathogenic organisms (PPOs) were identified. Blood cell counts and COPD Assessment Test (CAT) scores were collected at baseline and COPD symptoms measured over 12 months using the Evaluating Respiratory Symptoms in COPD and EXAcerbations of Chronic pulmonary disease Tool, collected by eDiary. Results: Patients (N=63) had a mean age of 72.8 years, and percent predicted post-bronchodilator forced expiratory volume in 1 second was 58.3%; 92% were male. Across 62 baseline sputum samples, microbiome composition was similar between 16S rRNA/metagenomic datasets. Patients graded Global Initiative for Chronic Obstructive Lung Disease (GOLD) III versus GOLD I/II had minimal differences in their microbial taxonomic profile and no differences in microbial diversity (Wilcoxon P=0.71). Alpha diversity (Shannon index) positively correlated with blood basophils (rho=0.41; P=0.0019) and negatively correlated with CAT score (rho=0.36; P=0.0069). Alpha diversity and sputum (rho: − 0.0637; P=0.7836) or blood (rho: 0.1739; P=0.2043) eosinophils were not correlated. No difference in alpha (P=0.5) or beta (P=0.3) diversity or Operational Taxonomic Unit (Anosim R=− 0.024; P=0.892) was observed between PPO-positive or -negative sputum. Conclusion: A less diverse microbiome correlated with poorer health status and lower blood basophils in patients with COPD and moderate airflow limitation. There was no relationship between PPO presence and microbiome diversity. Plain Language Summary: Chronic obstructive pulmonary disease (COPD) is a progressive lung condition resulting in breathing difficulties. Research has shown that patients with COPD experience changes in the diversity of bacteria in their lungs, leading to a worsening of symptoms. The lung microbiome includes different types of bacteria, and is involved in important roles, such as regulating the immune system and protecting the lung from invading pathogens. Many studies on the microbiome have been based in western countries, and there are few studies among Asian patients and populations with moderate COPD. The aim of this year-long study was to assess the diversity of the lung microbiome in Japanese patients with COPD and moderate airflow limitation, and how it affects patients’ immunity and disease severity. Patients’ sputum and blood samples were obtained at the start of the study and the different types of bacteria in the sputum and the number of immune cells in the blood were measured. Patients’ symptoms were also assessed at study start. Results showed that a less diverse lung microbiome was associated with lower levels of blood immune cells and worse COPD symptoms. These results improve our knowledge of the lung microbiome in an Asian population with COPD, providing insights into how lower bacterial diversity may worsen patient immunity and COPD severity.

27 June 2000 in Spinal Cord
Verified
Journal Article
Open access
PDF file
YSYoichi Shimada
Yoichi Shimada
EAE Abe
E Abe
KSK Sato
K Sato
Study design: A case report of congenital kyphosis corrected using a total en-bloc spondylectomy. Objectives: To report a new surgical technique for the treatment of congenital kyphosis with myelopathy. Setting: Department of Orthopedic Surgery, Akita University School of Medicine, Akita, Japan. Methods: A 16-year-old boy who showed a 61° angular kyphosis and a 32° scoliosis from T6 to T9 due to the failure of the vertebral bodies formation in T7 and T8 was treated with a total en-bloc spondylectomy. Results: The kyphosis was corrected to 26° (57.3%) and the scoliosis was corrected to 5° (84.4%) postoperatively. Three years postoperatively, no loss of correction has occurred and the patient has no complaints. Conclusions: Total en-bloc spondylectomy is one of the useful surgical procedures for correction of congenital kyphosis Type I, with a high correction rate.

13 October 2016
Verified
Book Chapter
Closed access
PDF file
KSKazuhiro Sato
Kazuhiro Sato
KYKohtaro Yuta
Kohtaro Yuta
YKYukinori Kusaka
Yukinori Kusaka